Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glutamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | GSR | P00390 | 2/20 | 0.64 |
| ▸ | GRM8 | O00222 | 2/20 | 0.64 |
| ▸ | GRM6 | O15303 | 2/20 | 0.64 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.64 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.64 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.64 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.64 |
| ▸ | GRM5 | P41594 | 1/20 | 0.64 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.64 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.64 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.64 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.64 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.64 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamine SCHEMBL851614 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL2765120 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL9716079 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL9716082 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL869882 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL2765188 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL1675307 | 1.00 | ALOX15 (0.83) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL15543979 | 0.98 | ALOX15 (0.79) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL28756768 | 0.96 | ALOX15 (0.76) | ALOX15BLMPMP22KMT2AGSR | |
| Glutamine SCHEMBL27557033 | 0.93 | KMT2A (0.86) | ALOX15BLMPMP22KMT2AGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105205-A1 | ANTIBODY-DRUG CONJUGATES (A2DCS) WITH ENZYMATICALLY CLEAVABLE GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-23 | — | — | WO | disclosed |
| US-20230227527-A1 | TCR-T CELL THERAPY TARGETING EPSTEIN-BARR VIRUS | TCRCURE BIOPHARMA CORP. | 2023-07-20 | — | — | US | disclosed |
| WO-2021013693-A1 | ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-01-28 | — | — | WO | disclosed |
| WO-2020255743-A1 | EVALUATION METHOD FOR FOOD RELATED TO COGNITIVE FUNCTION | 味の素株式会社 | 2020-12-24 | — | — | WO | disclosed |
| EP-3746079-A1 | ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS | Bayer Aktiengesellschaft (DE) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020158828-A1 | METHOD FOR EVALUATING FUTURE RISK OF OCCURRENCE OF CEREBRAL AND CARDIOVASCULAR EVENT, CALCULATION METHOD, EVALUATION DEVICE, CALCULATION DEVICE, EVALUATION PROGRAM, CALCULATION PROGRAM, STORAGE MEDIUM, EVALUATION SYSTEM, AND TERMINAL DEVICE | 味の素株式会社 | 2020-08-06 | — | — | WO | disclosed |
| WO-2019198601-A1 | METHOD, DEVICE AND PROGRAM FOR EVALUATING HEALTH STATUS AND/OR GROWTH STATUS OF LIVESTOCK | 味の素株式会社 | 2019-10-17 | — | — | WO | disclosed |
| WO-2019149637-A1 | ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2019-08-08 | — | — | WO | disclosed |
| WO-1991016923-A1 | NOVEL SYNTHETIC GRF ANALOGS | THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) | 1991-11-14 | — | — | WO | disclosed |
| EP-0216929-A1 | HUMAN ENDOGENOUS CANCER REGULATORY FACTORS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1987-04-08 | — | — | EP | disclosed |
| WO-1986004069-A1 | HUMAN ENDOGENOUS CANCER REGULATORY FACTORS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-07-17 | — | — | WO | disclosed |